SCHEMBL1084546

SCHEMBL1084546

Cc1ccc2c(N3CCCC3CN3CCCCC3)nc(-c3ccccc3O)nc2c1

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 6/20 0.47
L3MBTL1 Q9Y468 4/20 0.47
HIF1A Q16665 3/20 0.47
HTT P42858 1/20 0.47
KDM4E B2RXH2 4/20 0.46
SMAD3 P84022 1/20 0.46
CTNNB1 P35222 1/20 0.43
TCF7L2 Q9NQB0 1/20 0.43
KMT2A Q03164 3/20 0.41
MEN1 O00255 2/20 0.41
ALDH1A1 P00352 5/20 0.41
HPGD P15428 3/20 0.41
CHEK2 O96017 1/20 0.41
LMNA P02545 3/20 0.41
TDP1 Q9NUW8 3/20 0.41
HSD17B10 Q99714 2/20 0.41
TSHR P16473 2/20 0.41
NPSR1 Q6W5P4 1/20 0.41
USP2 O75604 1/20 0.41
MAPK1 P28482 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1084113 0.99 MAPT (0.47) MAPTL3MBTL1HIF1AHTTKDM4E
SCHEMBL1084253 0.89 MAPT (0.56) MAPTL3MBTL1HIF1AHTTKDM4E
SCHEMBL1084395 0.88 FLT3 (0.49) MAPTL3MBTL1HIF1AHTTKDM4E
SCHEMBL1084230 0.88 MAPT (0.60) MAPTL3MBTL1HIF1AHTTKDM4E
SCHEMBL1084498 0.87 MAPT (0.48) MAPTL3MBTL1HIF1AHTTKDM4E
SCHEMBL1084670 0.86 MAPT (0.49) MAPTL3MBTL1HIF1AHTTKDM4E
SCHEMBL1084753 0.86 MAPT (0.51) MAPTL3MBTL1HIF1AHTTKDM4E
SCHEMBL1084083 0.86 GBA1 (0.50) MAPTL3MBTL1HIF1AHTTKDM4E
SCHEMBL1084675 0.86 MAPT (0.49) MAPTL3MBTL1HIF1AHTTKDM4E
SCHEMBL1084706 0.86 MAPT (0.45) MAPTL3MBTL1HIF1AHTTKDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8343980-B2 Quinazoles useful as modulators of ion channels VERTEX PHARMACEUTICALS INCORPORATED (US) 2013-01-01 US disclosed
US-8343980-B2 Quinazoles useful as modulators of ion channels VERTEX PHARMACEUTICALS INCORPORATED (US) 2013-01-01 US disclosed
US-8153642-B2 Quinazolines useful as modulators of ion channels VERTEX PHARMACEUTICALS INCORPORATED (US) 2012-04-10 US disclosed
US-8153642-B2 Quinazolines useful as modulators of ion channels VERTEX PHARMACEUTICALS INCORPORATED (US) 2012-04-10 US disclosed
US-7713983-B2 Quinazolines useful as modulators of ion channels VERTEX PHARMACEUTICALS INCORPORATED (US) 2010-05-11 US disclosed
US-7713983-B2 Quinazolines useful as modulators of ion channels VERTEX PHARMACEUTICALS INCORPORATED (US) 2010-05-11 US disclosed
US-7678802-B2 Quinazolines useful as modulators of ion channels VERTEX PHARMACEUTICALS INCORPORATED (US) 2010-03-16 US disclosed
US-7678802-B2 Quinazolines useful as modulators of ion channels VERTEX PHARMACEUTICALS INCORPORATED (US) 2010-03-16 US disclosed